VERU

Veru Inc. - Common Stock (VERU)

About Veru Inc. - Common Stock (VERU)

Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines and treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. The company was founded by William R. Gargiulo, Jr. and O. B. Parrish in 1971 and is headquartered in Miami, FL.

Details

Daily high

$2.14

Daily low

$2.07

Price at open

$2.08

52 Week High

$7.33

52 Week Low

$2.04

Market cap

35.1M

Dividend yield

Volume

81,150

Avg. volume

158,449

P/E ratio

-3.37

Veru Inc. - Common Stock News